polymorphisms may account for 2-16% of the variability of LDL cholesterol levels, a contribution incomparable with any other gene in the general population. [2, 3] Compared with ε3 homozygotes, carriers of the ε2 allele, which has defective receptor-binding ability, have lower circulating cholesterol levels and higher triglyceride levels, whereas carriers of the ε4 allele appear to have higher plasma levels of total and low-density lipoprotein cholesterol.
[1]
Since the first demonstration of apoE gene polymorphism on dysbetalipoproteinemia, [7] numerous studies have investigated the relation between apoE genotypes and coronary heart disease (CHD). [7] [8] [9] Recent evidence also indicates that apoE may play additional role in the development of CHD. [2, [10] [11] [12] [13] Globally, the apoE locus shows substantial allelic variation with ranges 0-20% for ε2, 60-90% for ε3 and 10-20% for ε4 alleles [14] [15] [16] [17] [18] with some exception. In Asian Indians, studies have investigated the allele frequencies with ranges 0.031-0.094 for ε2; 0.803-0.968 for ε3 and 0.000-0.133 for ε4.
[19] Frequency of apoE ε3 allele was found to be high (0.913) in people of north India. [17] In another study on Asian Indians, individuals with at least a ε4 allele were considered at risk to develop premature Myocardial Infarction (MI), independent of other risk conventional risk factors. [20] Most of these studies are either from the north, west, central, and southern part of India. [15, Studies from eastern part of India are
Introduction
Apolipoprotein E (apoE) plays a key role in the metabolism of cholesterol and triglyceride by serving as a receptor binding ligand mediating the clearance of chylomicron and remnants of very low-density lipoprotein cholesterol from plasma. [1] [2] [3] [4] Three different apoE alleles (ε2, ε3, and ε4) on chromosome number 19 are responsible to encoding three different apo E isoform (apo E2, apo E3, and apo E4 respectively),
lacking. The present study is an attempt to investigate the apo E gene polymorphism and its association with dyslipidemmia in people belongs to the eastern part of India.
Materials and Methods

Study population
The data were collected from adult men and women aged 30 years and above from Calcutta and suburb. A total of 350 individuals (184 males and 166 females) participated in the study. Prior to participation, public advertisement was given about the study with the help of the council officials. An arbitrary list was made to conduct the study. Individuals were selected randomly after their response through local advertisement. The response rate was quite high (~85%). The institute ethical committee has had approved the study. Written consent was obtained from participants prior to actual commencement of the study.
Anthropometric measurements
Anthropometric variables namely height, weight, circumference of waist (WC) and hip were taken using standard techniques. [36]
Genotyping DNA was extracted from blood using QI Aamp Kit (QIAGEN, Germany). Apo E isoforms were amplified by polymerase chain reaction with a thermal cycler (Bio Rad, USA) and specific oligonucleotides as described.
[37] The amplified fragments were digested with the enzyme HhaI overnight at 37°C and separated on a 4% agarose (Promega, USA) gel electrophoresis with ethidium bromide staining and visualized under UV spectrophotometer.
Statistical analyses
Descriptive statistics such mean and standard deviation (SD) of anthropometric and biochemical measures was calculated by sex and the sex differences for these variables were calculated using unpaired t test.
Differences in genotype frequency were examined by χ 2 analyses. Analysis of variance (ANOVA) was undertaken to see the differences of obesity and metabolic variables across the apo E genotypes.
All statistical analyses were computed using the SPSS (PC + version10.0). [38] A P value of <0.05 (two tailed) was considered as significant.
Results
The mean and SD (unadjusted for age) of anthropometric, lipids profile and blood glucose variables by sexes are presented in Table 1 . There existed no significant sex differences for variables except for age, TC and FBG. Since, age differed significantly, age and sex matched 70 subjects were selected randomly to study the association of apo E polymorphism and dyslipidaemia.
The distribution of risk variables by apo E genotypes are presented in The incidence of dyslipidaemia by apo E genotypes is presented in Table 3 . The Chi-square revealed significant (P=0.0135) group differences in incidence of dyslipidaemia by genotypes. Incidence percentage of dyslipidaemia is shown in Figure 1 . The incidence is 25% for ε2/3, 75% for ε3/4, 63.64% for ε3/3 and 100% for ε4/4 genotypes.
Discussion
The present investigation was aimed to examine whether significant association does exist between apo ε2/4< ε2/3. In a similar study on Omani dyslipidaemic patients, it was observed that thirty-one percent of patients with CHD had the APOE*4 allele compared to 26% with the APOE*3 allele, but this difference was not significant. [39] In another study, it was observed that the prevalence of the ε4-containing phenotypes were significantly higher in ischemic patients and that apo ε4 is an independent risk factor associated with an altered lipid profiles. [40] In the Ouro Preto admixed population in Brazil, it demonstrated that the presence of APOE*2 can confer a protective effect, whereas the presence of APOE*4 implies an enhanced risk for dyslipidemia.
[41]
The major limitation of the study was that it was performed on a small sample size and therefore is not representative of Asian Indian population.
Owing to ethnic and cultural heterogeneity in Asian Indian population, it is imperative to study the ethnic groups collectively, possibly through collaborative research. This will give more insight into proper understanding of the association lying between apo E gene polymorphisms and dyslipidaemia among Asian Indians.
Conclusion
It seems that the allele frequency of ε4 is quite high in the present studied population as compare to most of the other parts of India. Prevalence of dyslipidaemia is significantly high among individuals with ε3/4 and ε4/4 genotypes compare to other combinations. It seems reasonable to argue that ε4 allele has an independent effect on lipids metabolism particularly increased TC: HDLc ratio causing dyslipidaemia in the study population.
